Weglewska-Jurkiewicz Anna, Jakóbkiewicz-Banecka Joanna, Pronicka Ewa, Wegrzyn Grzegorz
Department of Molecular Biology, University of Gdañsk, Kładki 24, 80-822 Gdañsk, Poland.
Diagn Mol Pathol. 2007 Jun;16(2):116-20. doi: 10.1097/PDM.0b013e3180336271.
Human mitochondrial diseases are usually caused by dysfunction of mitochondrial DNA (mtDNA), particularly by point mutations, deletions, or depletions. In commonly used procedures for molecular diagnostics of mitochondrial dysfunction, one of the first steps is linearization of circular mitochondrial genomes with either BamHI or PvuII restriction endonulease, which cuts human mtDNA at a unique site. Here, we describe a case of false positive results, which suggested mtDNA depletion or a large deletion in a patient's tissue sample. More detailed analysis (mtDNA sequencing) revealed that these false positive results were caused by the presence of the 12753A>G substitution in the gene coding for NADH dehydrogenase subunit 5 (ND5). This substitution results in no change in amino acid sequence of the gene product but creates an additional PvuII site. Investigating a population of 200 patients not affected by mitochondrial diseases, we found an additional case of 12753A>G, and also another substitution, 12804T>C, which also results in no change in amino acid sequence of ND5 but creates an additional PvuII site. A few cases of 12753A>G and 12804T>C substitutions were found previously in Asian, American, African, and European populations (though they were not reported to date in the MITOMAP), but those samples were used in population studies and not tested for mtDNA deletion or depletion. Therefore, we present a cautionary report indicating that these mtDNA polymorphisms exist in various human populations (and thus, they are panethnic) and may cause false positive results of standard molecular analyses, including molecular diagnostics, of human mtDNA.
人类线粒体疾病通常由线粒体DNA(mtDNA)功能障碍引起,尤其是点突变、缺失或耗竭。在常用的线粒体功能障碍分子诊断程序中,首要步骤之一是用BamHI或PvuII限制性内切酶将环状线粒体基因组线性化,这两种酶在人类mtDNA的独特位点进行切割。在此,我们描述了一例假阳性结果的病例,该结果提示患者组织样本中存在mtDNA耗竭或大片段缺失。更详细的分析(mtDNA测序)显示,这些假阳性结果是由烟酰胺腺嘌呤二核苷酸脱氢酶亚基5(ND5)编码基因中12753A>G替换的存在所导致。这种替换不会导致基因产物的氨基酸序列发生变化,但会产生一个额外的PvuII位点。在对200名未患线粒体疾病的患者群体进行调查时,我们发现了另外一例12753A>G替换,以及另一种替换12804T>C,后者同样不会导致ND5的氨基酸序列发生变化,但会产生一个额外的PvuII位点。此前在亚洲、美洲、非洲和欧洲人群中发现了一些12753A>G和12804T>C替换的病例(尽管迄今为止在MITOMAP中尚未报道),但这些样本用于群体研究,未检测mtDNA缺失或耗竭情况。因此,我们发布一份警示报告,指出这些mtDNA多态性存在于不同人类群体中(因此,它们是泛种族的),可能会导致人类mtDNA标准分子分析(包括分子诊断)出现假阳性结果。